Literature DB >> 31664426

Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE.

John S Barbieri1, Ilona J Frieden2, Arielle R Nagler3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31664426     DOI： 10.1001/jamadermatol.2019.3270

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

1.  A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris.

Authors:  James Q Del Rosso; Sandra Marchese Johnson; Todd Schlesinger; Lawrence Green; Nestor Sanchez; Edward Lain; Zoe Draelos; Jean-Philippe York; Rajeev Chavda
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

2.  Exploring the costs associated with isotretinoin treatment.

Authors:  Nidhi Shah; Morgan Byrne; Anna Yasmine Kirkorian
Journal:  Pediatr Dermatol       Date:  2021-08-31       Impact factor: 1.997

3.  Simplifying contraception requirements for iPLEDGE: A decision analysis.

Authors:  John S Barbieri; Andrea H Roe; Arash Mostaghimi
Journal:  J Am Acad Dermatol       Date:  2020-02-14       Impact factor: 11.527
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.